Advances in the management of atrial fibrillation with a special focus on non-pharmacological approaches to prevent thromboembolism: a review of current recommendations.

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
Malini RiddleHarsha Nagarajarao

Abstract

Atrial fibrillation (AFIB) is the most common heart rhythm abnormality and is associated with significant morbidity and mortality. While the treatment of AFIB involves strategies of rate with or without rhythm control, it is also essential to strategize appropriate therapies to prevent thromboembolic complications arising from AFIB. Previously, anticoagulation was the main treatment option which exposed patients to higher than usual risk of bleeding. However, with the advent of new technology, novel therapeutic options aimed at surgical or percutaneous exclusion or occlusion of the left atrial appendage in preventing thromboembolic complications from AFIB have evolved. This review evaluates recent advances and therapeutic options in treating AFIB with a special focus on both surgical and percutaneous interventions which can reduce and/or eliminate thromboembolic complications of AFIB.

References

Oct 1, 1976·The American Journal of Cardiology·R W Koster, H J Wellens
Aug 1, 1991·Circulation·J A Cairns
Nov 15, 1990·The American Journal of Cardiology·C K WongC H Cheng
Feb 1, 1987·European Heart Journal·K S ChannerJ R Rees
Jul 1, 1995·Age and Ageing·P J Lawson-MatthewK S Channer
Sep 1, 1994·Journal of the American College of Cardiology·D Y LeungW F Walsh
Jun 15, 1994·The American Journal of Cardiology·M A BrodskyY S Orlov
Feb 1, 1996·The Annals of Thoracic Surgery·J L Blackshear, J A Odell
Sep 3, 1998·The New England Journal of Medicine·M HaïssaguerreJ Clémenty
Aug 10, 1999·Journal of the American College of Cardiology·A M ChoyD M Roden
Aug 10, 2000·Journal of the American College of Cardiology·E S KatzI Kronzon
Jun 5, 2002·Circulation·Shunichi HommaUNKNOWN PFO in Cryptogenic Stroke Study (PICSS) Investigators
Dec 6, 2002·The New England Journal of Medicine·D G WyseUNKNOWN Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
Dec 6, 2002·The New England Journal of Medicine·Isabelle C Van GelderUNKNOWN Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group
Oct 3, 2003·Journal of the American College of Cardiology·Miguel Angel García-FernándezJacobo Silva
Aug 11, 2004·Chest·Grzegorz OpolskiUNKNOWN Investigators of the Polish How to Treat Chronic Atrial Fibrillation Study
Mar 11, 2006·European Heart Journal·Jan HeeringaJacqueline C M Witteman
Jun 21, 2008·The New England Journal of Medicine·Denis RoyUNKNOWN Atrial Fibrillation and Congestive Heart Failure Investigators
Sep 6, 2008·Journal of the American College of Cardiology·Anne S KanderianAllan L Klein
Nov 26, 2008·Circulation·Pierre JaïsMichel Haïssaguerre
Dec 9, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Satoshi OgawaUNKNOWN J-RHYTHM Investigators
Nov 11, 2009·Circulation·David R Holmes, Robert S Schwartz
Jan 28, 2010·JAMA : the Journal of the American Medical Association·David J WilberUNKNOWN ThermoCool AF Trial Investigators
Mar 17, 2010·The New England Journal of Medicine·Isabelle C Van GelderUNKNOWN RACE II Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.